Back to results
US 7,125,997 B2Granted
Differential tumor cytotoxicity compounds and compositions
AssigneeIrm LLC
InventorsJason Chyba, Quinn Devereax, Garret Hampton, Fred King
Life of this patent
Estimating the term…
Abstract
The invention is directed to novel biaryl derivatives, to the uses of these compounds in various medicinal applications, including the treatment, prevention and control of proliferative diseases such as tumors, and to pharmaceutical compositions comprising these compounds. Compounds of the invention can be used to treat or prevent diseases or disorders that involve the activity of MIF-1 and/or adenosine kinase.
Claims1
A compound selected from:
- N-(4-Morpholin-4-yl-phenyl)-4-(4-trifluoromethoxy-phenylamino)-benzamide;
- N-(4-Morpholin-4-yl-phenyl)-4-(4-phenoxy-phenylamino)-benzamide;
- N-[2-(4-Methoxy-phenyl)-ethyl]-4-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-benzamide;
- 3-[6-(4-Trifluoromethoxy-phenylamino)-pyrimidin-4-yl]-N-(2-trifluoromethyl-benzyl)-benzamide;
- and N-[2-(4-hydroxy-phenyl)-ethyl]-4-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-benzamide.
2 more elements
Dependencies are inferred from the claim text.